These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19383829)

  • 1. IRF4: Immunity. Malignancy! Therapy?
    Shaffer AL; Emre NC; Romesser PB; Staudt LM
    Clin Cancer Res; 2009 May; 15(9):2954-61. PubMed ID: 19383829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of interferon regulatory factor 4 (IRF4) in immune cell development.
    Nam S; Lim JS
    Arch Pharm Res; 2016 Nov; 39(11):1548-1555. PubMed ID: 27826752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF4 in multiple myeloma-Biology, disease and therapeutic target.
    Agnarelli A; Chevassut T; Mancini EJ
    Leuk Res; 2018 Sep; 72():52-58. PubMed ID: 30098518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF4 addiction in multiple myeloma.
    Shaffer AL; Emre NC; Lamy L; Ngo VN; Wright G; Xiao W; Powell J; Dave S; Yu X; Zhao H; Zeng Y; Chen B; Epstein J; Staudt LM
    Nature; 2008 Jul; 454(7201):226-31. PubMed ID: 18568025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUM1/IRF4: A Review.
    Gualco G; Weiss LM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):301-10. PubMed ID: 20182347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory network of BLIMP1, IRF4, and XBP1 triad in plasmacytic differentiation and multiple myeloma pathogenesis.
    Tang TF; Chan YT; Cheong HC; Cheok YY; Anuar NA; Looi CY; Gan GG; Wong WF
    Cell Immunol; 2022 Oct; 380():104594. PubMed ID: 36081178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRF4 promotes cell proliferation by JNK pathway in multiple myeloma.
    Zhang S; Xu J; Wu S; Wang R; Qu X; Yu W; Li J; Chen L
    Med Oncol; 2013; 30(2):594. PubMed ID: 23666852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development.
    Yamamoto M; Kato T; Hotta C; Nishiyama A; Kurotaki D; Yoshinari M; Takami M; Ichino M; Nakazawa M; Matsuyama T; Kamijo R; Kitagawa S; Ozato K; Tamura T
    PLoS One; 2011; 6(10):e25812. PubMed ID: 22003407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular choreography of IRF4 and IRF8 with immune system partners.
    Singh H; Glasmacher E; Chang AB; Vander Lugt B
    Cold Spring Harb Symp Quant Biol; 2013; 78():101-4. PubMed ID: 24752218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis.
    Low MSY; Brodie EJ; Fedele PL; Liao Y; Grigoriadis G; Strasser A; Kallies A; Willis SN; Tellier J; Shi W; Gabriel S; O'Donnell K; Pitt C; Nutt SL; Tarlinton D
    Cell Rep; 2019 Nov; 29(9):2634-2645.e5. PubMed ID: 31775034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma.
    Bolomsky A; Ceribelli M; Scheich S; Rinaldi K; Huang DW; Chakraborty P; Pham L; Wright GW; Hsiao T; Morris V; Choi J; Phelan JD; Holewinski RJ; Andresson T; Wisniewski J; Riley D; Pittaluga S; Hill E; Thomas CJ; Muppidi J; Young RM
    Cancer Cell; 2024 Jul; 42(7):1185-1201.e14. PubMed ID: 38906156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.
    Ueno N; Nishimura N; Ueno S; Endo S; Tatetsu H; Hirata S; Hata H; Matsuoka M; Mitsuya H; Okuno Y
    Oncogene; 2017 Aug; 36(31):4481-4497. PubMed ID: 28368411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4.
    Carreras E; Turner S; Frank MB; Knowlton N; Osban J; Centola M; Park CG; Simmons A; Alberola-Ila J; Kovats S
    Blood; 2010 Jan; 115(2):238-46. PubMed ID: 19880499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages.
    Lehtonen A; Veckman V; Nikula T; Lahesmaa R; Kinnunen L; Matikainen S; Julkunen I
    J Immunol; 2005 Nov; 175(10):6570-9. PubMed ID: 16272311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diverse roles of IRF4 in late germinal center B-cell differentiation.
    De Silva NS; Simonetti G; Heise N; Klein U
    Immunol Rev; 2012 May; 247(1):73-92. PubMed ID: 22500833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.
    Klein U; Casola S; Cattoretti G; Shen Q; Lia M; Mo T; Ludwig T; Rajewsky K; Dalla-Favera R
    Nat Immunol; 2006 Jul; 7(7):773-82. PubMed ID: 16767092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity.
    Simonetti G; Carette A; Silva K; Wang H; De Silva NS; Heise N; Siebel CW; Shlomchik MJ; Klein U
    J Exp Med; 2013 Dec; 210(13):2887-902. PubMed ID: 24323359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive intranuclear flow cytometric quantification of IRF4 protein in multiple myeloma and normal human hematopoietic cells.
    Vora AA; Mondala PK; Costello C; MacLeod AR; Crews LA
    STAR Protoc; 2021 Jun; 2(2):100565. PubMed ID: 34136833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage- and Stage-Specific Oncogenicity of IRF4.
    Amanda S; Tan TK; Iida S; Sanda T
    Exp Hematol; 2022 Oct; 114():9-17. PubMed ID: 35908629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.